These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 24656316

  • 1. Cost-utility analysis of sodium polystyrene sulfonate vs. potential alternatives for chronic hyperkalemia.
    Little DJ, Nee R, Abbott KC, Watson MA, Yuan CM.
    Clin Nephrol; 2014 Apr; 81(4):259-68. PubMed ID: 24656316
    [Abstract] [Full Text] [Related]

  • 2. Little D, Nee R, Abbott K, et al. Cost utility analysis of sodium polystyrene sulfate vs. potential alternatives for chronic hyperkalemia. Clinical Nephrology, 2014; 81: 259-268.
    Straube B, Reaven N, Funk S.
    Clin Nephrol; 2015 Jun; 83(6):380-1. PubMed ID: 26221659
    [No Abstract] [Full Text] [Related]

  • 3. Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.
    Lepage L, Dufour AC, Doiron J, Handfield K, Desforges K, Bell R, Vallée M, Savoie M, Perreault S, Laurin LP, Pichette V, Lafrance JP.
    Clin J Am Soc Nephrol; 2015 Dec 07; 10(12):2136-42. PubMed ID: 26576619
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.
    Georgianos PI, Liampas I, Kyriakou A, Vaios V, Raptis V, Savvidis N, Sioulis A, Liakopoulos V, Balaskas EV, Zebekakis PE.
    Int Urol Nephrol; 2017 Dec 07; 49(12):2217-2221. PubMed ID: 29027620
    [Abstract] [Full Text] [Related]

  • 5. Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia.
    Bounthavong M, Butler J, Dolan CM, Dunn JD, Fisher KA, Oestreicher N, Pitt B, Hauptman PJ, Veenstra DL.
    Pharmacoeconomics; 2018 Dec 07; 36(12):1463-1473. PubMed ID: 30194623
    [Abstract] [Full Text] [Related]

  • 6. Sodium polystyrene sulfonate: a cation exchange resin used in treating hyperkalemia.
    Meyer I.
    ANNA J; 1993 Feb 07; 20(1):93-5. PubMed ID: 8431031
    [Abstract] [Full Text] [Related]

  • 7. Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age.
    Noel JA, Bota SE, Petrcich W, Garg AX, Carrero JJ, Harel Z, Tangri N, Clark EG, Komenda P, Sood MM.
    JAMA Intern Med; 2019 Aug 01; 179(8):1025-1033. PubMed ID: 31180477
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Potassium-Binding Agents to Facilitate Renin-Angiotensin-Aldosterone System Inhibitor Therapy.
    Schaefer JA, Gales MA.
    Ann Pharmacother; 2016 Jun 01; 50(6):502-10. PubMed ID: 27009290
    [Abstract] [Full Text] [Related]

  • 10. Polysulfonate Resins in Hyperkalemia: A Systematic Review.
    Wong SWS, Zhang G, Norman P, Welihinda H, Wijeratne DT.
    Can J Kidney Health Dis; 2020 Jun 01; 7():2054358120965838. PubMed ID: 33240515
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Secondary prevention of hyperkalemia with sodium polystyrene sulfonate in cardiac and kidney patients on renin-angiotensin-aldosterone system inhibition therapy.
    Chernin G, Gal-Oz A, Ben-Assa E, Schwartz IF, Weinstein T, Schwartz D, Silverberg DS.
    Clin Cardiol; 2012 Jan 01; 35(1):32-6. PubMed ID: 22057933
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. New drugs to prevent and treat hyperkalemia.
    Lepage L, Desforges K, Lafrance JP.
    Curr Opin Nephrol Hypertens; 2016 Nov 01; 25(6):524-528. PubMed ID: 27584929
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sodium polystyrene sulfonate resin candy for control of potassium in chronic dialysis patients.
    Johnson K, Cazee C, Gutch C, Ogden D.
    Clin Nephrol; 1976 Jun 01; 5(6):266-8. PubMed ID: 1277599
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice.
    Davidson JP, King AJ, Kumaraswamy P, Caldwell JS, Korner P, Blanks RC, Jacobs JW.
    J Cardiovasc Pharmacol Ther; 2018 May 01; 23(3):244-253. PubMed ID: 29130735
    [Abstract] [Full Text] [Related]

  • 20. Potassium Binders for Hyperkalemia in Chronic Kidney Disease-Diet, Renin-Angiotensin-Aldosterone System Inhibitor Therapy, and Hemodialysis.
    Palmer BF.
    Mayo Clin Proc; 2020 Feb 01; 95(2):339-354. PubMed ID: 31668450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.